There are thousands of drugs that silence many thousands of cancer-causing genetic abnormalities.
Some of these drugs are in use now, but many of these drugs are sitting on shelves or could be used beyond the disease for which they were originally approved. Repurposing these drugs depends on matching drugs to targets. A study recently published in the journal Bioinformatics describes a new database and pattern-matching algorithm that allows researchers to evaluate rational drugs and drug combinations, and also recommends a new drug combination to treat drug-resistant non-small cell lung cancer.
Read more . . .
The Latest on: Matching drugs to targets
[google_news title=”” keyword=”Matching drugs to targets” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Matching drugs to targets
- Researchers mark milestone in progress toward investigational new drug for triple-negative breast canceron July 22, 2024 at 9:53 am
A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer—and could potentially be applied to fibrotic ...
- MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistanceon July 22, 2024 at 5:40 am
New findings highlight potential advantages of MIRA's novel oral ketamine analog for treating neurological and neuropsychiatric disorders MIAMI, ...
- Combination therapy incorporating three existing drugs shows potential for treating retinal degenerationson July 22, 2024 at 4:03 am
Drug repurposing shows promise in the treatment of retinal degenerations, according to a new study by an international team of researchers, published in Nature Communications.
- Health Advocates Target the U.S. Launch of Philip Morris' Heated Tobacco Products. Is the Stock in Trouble?on July 21, 2024 at 11:47 am
Altria had held the exclusive rights to sell IQOS in the U.S. following its spinoff from of Philip Morris in 2008. However, as a result of a patent infringement case brought by peer British American ...
- Bone marrow donors needn’t be perfect match, study says, paving way for more equitable accesson July 20, 2024 at 12:33 pm
It's much less likely that cancer patients who are racial minorities find the perfect match for a bone marrow transplant. A new study finds that maybe imperfect donor matches will still work well.
- Scientists pinpoint new drug target for RSVon July 18, 2024 at 5:00 pm
"Scientists pinpoint new drug target for RSV." ScienceDaily. www.sciencedaily.com / releases / 2024 / 07 / 240719123853.htm (accessed July 19, 2024). Explore More ...
- Pegcetacoplan Comes Out Ahead in Comparison of Drugs for Dry AMDon July 18, 2024 at 12:15 pm
STOCKHOLM -- Atrophic age-related macular degeneration control appeared better with pegcetacoplan (Syfovre) as compared with avacincaptad pegol (Izervay) in a propensity-matched cross-trial comparison ...
- Scientists pinpoint new drug target for RSVon July 18, 2024 at 8:23 am
Scientists have discovered how the dangerous respiratory syncytial virus (RSV) defuses our immune response and, in doing so, have pinpointed an exciting new target for drug developers.
- At least half a million migrants were deported in the last 20 years for drug violations that no longer existon July 17, 2024 at 12:31 pm
A recent Human Rights Watch and the Drug Policy Alliance report shows how ineffective drug policies intersect with a broken immigration system to further split families apart and disrupt communities.
- Match Group gets heat from another activist investoron July 16, 2024 at 9:35 am
Match should consider cutting general and administrative costs and target an adjusted operating margin of more ... Mark Cuban’s Cost Plus Drug Co. to import syphilis drug amid long-running U.S.
via Bing News
